Brainstorm Cell Therapeutics | BCLI - Trade Creditors


Brainstorm Cell Therapeutics reported $6.42M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.27M 1.81M Dec/2024
Biogen USD 432M 18.9M Dec/2025
Brainstorm Cell Therapeutics USD 6.42M 423K Sep/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 9.12M 7.33M Sep/2025
CSL USD 3.46B 484M Jun/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
Grifols EUR 1.04B 183.31M Jun/2025
Halozyme Therapeutics USD 15.36M 3.33M Sep/2025
Mesoblast USD 19.08M 7.22M Jun/2025